Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians.

Autor: Hensen L; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia., Nguyen THO; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia., Rowntree LC; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia., Damelang T; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia., Koutsakos M; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia., Aban M; World Health Organization Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia., Hurt A; World Health Organization Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia., Harland KL; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia., Auladell M; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia., van de Sandt CE; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia.; Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands., Everitt A; Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia., Blacker C; Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia., Oyong DA; Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia.; Center for Global Infectious Disease Research (CGIDR), Seattle Children's Research Institute, Seattle, WA 98109., Loughland JR; Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia.; Immunology Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia., Webb JR; Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia., Wines BD; Immune Therapies Laboratory, Burnet Institute, Melbourne, VIC 3084, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC 3010, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3010, Australia., Hogarth PM; Immune Therapies Laboratory, Burnet Institute, Melbourne, VIC 3084, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC 3010, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3010, Australia., Flanagan KL; Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, TAS 7250, Australia.; School of Health Sciences and School of Medicine, University of Tasmania, Launceston, TAS 7248, Australia.; Department of Immunology and Pathology, Monash University, Melbourne, VIC 3800, Australia.; School of Health and Biomedical Science, Royal Melbourne Institute of Technology, Melbourne, VIC 3000, Australia., Plebanski M; School of Health and Biomedical Science, Royal Melbourne Institute of Technology, Melbourne, VIC 3000, Australia., Wheatley A; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia.; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC 3010, Australia., Chung AW; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia., Kent SJ; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia.; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC 3010, Australia.; Infectious Diseases Department, Melbourne Sexual Health Centre, Alfred Health, Central Clinical School, Monash University, Melbourne, VIC 3053, Australia., Miller A; Indigenous Engagement, Central Queensland University, Townsville, QLD 4810, Australia., Clemens EB; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia., Doherty PC; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia; pcd@unimelb.edu.au kkedz@unimelb.edu.au.; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105., Nelson J; Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia., Davies J; Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia.; Department of Infectious Diseases, Royal Darwin Hospital, Darwin, NT 0810, Australia., Tong SYC; Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia.; Victorian Infectious Diseases Service, The Royal Melbourne Hospital and The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia., Kedzierska K; Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia; pcd@unimelb.edu.au kkedz@unimelb.edu.au.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Oct 12; Vol. 118 (41).

Age-Related Decline in Primary CD8 ⁺ T Cell Responses Is Associated with the Development of Senescence in Virtual Memory CD8 ⁺ T Cells.

Autor: Quinn KM; Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia. Electronic address: kylie.quinn@monash.edu., Fox A; Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia., Harland KL; Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia., Russ BE; Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, VIC 3800, Australia., Li J; Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, VIC 3800, Australia., Nguyen THO; Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia., Loh L; Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia., Olshanksy M; Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, VIC 3800, Australia., Naeem H; Bioinformatics Platform, Monash University, Melbourne, VIC 3800, Australia., Tsyganov K; Bioinformatics Platform, Monash University, Melbourne, VIC 3800, Australia., Wiede F; Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Webster R; Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia., Blyth C; Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia., Sng XYX; Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia., Tiganis T; Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Powell D; Bioinformatics Platform, Monash University, Melbourne, VIC 3800, Australia., Doherty PC; Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia; Department of Immunology, St Jude Children's Research Hospital, Memphis, TN 38105, USA., Turner SJ; Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia; Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, VIC 3800, Australia., Kedzierska K; Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia., La Gruta NL; Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Department of Microbiology and Immunology, The Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia. Electronic address: nicole.la.gruta@monash.edu.

Publikováno v: Cell reports [Cell Rep] 2018 Jun 19; Vol. 23 (12), pp. 3512-3524.

Understanding CD8 ⁺ T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope.

Autor: Nguyen TH; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Tan AC; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; PX Biosolutions, South Melbourne, Victoria, Australia., Xiang SD; PX Biosolutions, South Melbourne, Victoria, Australia.; Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia., Goubier A; PX Biosolutions, South Melbourne, Victoria, Australia., Harland KL; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Clemens EB; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Plebanski M; PX Biosolutions, South Melbourne, Victoria, Australia.; Department of Immunology and Pathology, Monash University, Melbourne, Victoria, Australia., Kedzierska K; Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Publikováno v: Clinical & translational immunology [Clin Transl Immunology] 2017 Mar 17; Vol. 6 (3), pp. e134. Date of Electronic Publication: 2017 Mar 17 (Print Publication: 2017).